Subhasree Basu, Ph.D.
Affiliations: | 2013 | Neuroscience | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
General Biology, Cell BiologyGoogle:
"Subhasree Basu"Mean distance: 35622
Parents
Sign in to add mentor| A Sue Menko | grad student | 2013 | Thomas Jefferson | |
| (Signaling pathways crucial in differentiation initiation and terminal differentiation during lens development.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Webster MR, Fane ME, Alicea GM, et al. (2019) Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Molecular Cell |
| Veglia F, Tyurin VA, Blasi M, et al. (2019) Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature |
| Parris J, Basu S, Barnoud T, et al. (2019) Abstract 4847: Investigating the impact of astrocytes on targeted therapy of melanoma brain metastases Cancer Research. 79: 4847-4847 |
| Gnanapradeepan K, Basu S, Kung C, et al. (2019) Abstract 3483: The African-specific S47 variant of the p53 tumor suppressor gene alters cell metabolism Cancer Research. 79: 3483-3483 |
| Barnoud T, Budina-Kolomets A, Basu S, et al. (2018) Tailoring chemotherapy for the African-centric S47 variant of TP53. Cancer Research |
| Gnanapradeepan K, Basu S, Barnoud T, et al. (2018) The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. Frontiers in Endocrinology. 9: 124 |
| Basu S, Gnanapradeepan K, Barnoud T, et al. (2018) Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. Genes & Development |
| Barnoud T, Basu S, Kung C, et al. (2018) Abstract B210: BET inhibitors show superior ability to suppress the progression of tumors containing the Pro47Ser single-nucleotide polymorphism of p53 Molecular Cancer Therapeutics. 17 |
| Webster MR, Kaur A, Ndoye A, et al. (2017) Abstract 4913: Invasive melanoma cells commandeer p53 activity to promote the survival of a therapy resistant subpopulation Cancer Research. 77: 4913-4913 |
| Chatwichien J, Basu S, Budina-Kolomets A, et al. (2016) PUMA-dependent apoptosis in NSCLC cancer cells by a dimeric β-carboline. Bioorganic & Medicinal Chemistry Letters |